Art Taveras
Chief Tech/Sci/R&D Officer bei X4 PHARMACEUTICALS, INC.
Vermögen: 325 678 $ am 31.03.2024
Profil
Art Taveras is the founder of Transform Therapeutics, which was founded in 2015.
He held the title of Chief Scientific Officer & Head-Drug Discovery from 2015 to 2020.
Currently, he is the Chief Scientific Officer at X4 Pharmaceuticals, Inc. since 2020.
Dr. Taveras has held several former positions, including Vice President-Drug Discovery & Development at Alantos Pharmaceuticals Holding, Inc. from 2004 to 2007, Vice President-Small Molecule Drug Discovery at Biogen Idec, Inc. (North Carolina) from 2007 to 2013, President & Chief Scientific Officer at Shanghai ChemPartner Co., Ltd.
from 2013 to 2014, and Chief Scientific Officer at Comet Therapeutics, Inc. from 2018 to 2020.
Dr. Taveras received his undergraduate, graduate, and doctorate degrees from Rensselaer Polytechnic Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
0,14% | 11.03.2024 | 234 301 ( 0,14% ) | 325 678 $ | 31.03.2024 |
Aktive Positionen von Art Taveras
| Unternehmen | Position | Beginn |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 02.11.2020 |
Ehemalige bekannte Positionen von Art Taveras
| Unternehmen | Position | Ende |
|---|---|---|
| Transform Therapeutics | Founder | 01.11.2020 |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.07.2020 |
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | President | 01.12.2014 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Corporate Officer/Principal | 01.01.2013 |
Alantos Pharmaceuticals Holding, Inc.
 Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01.11.2007 |
Ausbildung von Art Taveras
| Rensselaer Polytechnic Institute | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Alantos Pharmaceuticals Holding, Inc.
Alantos Pharmaceuticals Holding, Inc. Pharmaceuticals: MajorHealth Technology Alantos Pharmaceuticals Holding, Inc. manufactures bio-pharmaceutical products. The firm develops small molecule compounds for inflammatory cytokine pathways. The company was founded in 1999 and is headquartered in Thousand Oaks, CA. | Health Technology |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Shanghai ChemPartner Co., Ltd.
Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China. | Commercial Services |
Comet Therapeutics, Inc.
Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA. | Health Technology |
| Transform Therapeutics |
